Opinion pieces from oncology specialists in Australia and around the world.
ESMO Debate: Should Neoadjuvant Data Be Used To Speed Drug Approval?
VIENNA—Can neoadjuvant breast cancer data be used to accelerate drug development? At the recent annual…